Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Equity Average (2019 - 2022)

NovaBridge Biosciences (NBP) has disclosed Equity Average for 4 consecutive years, with $561.2 million as the latest value for Q4 2022.

  • Quarterly Equity Average fell 28.16% to $561.2 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $561.2 million through Dec 2022, down 28.16% year-over-year, with the annual reading at $566.5 million for FY2022, 28.18% down from the prior year.
  • Equity Average for Q4 2022 was $561.2 million at NovaBridge Biosciences, down from $781.1 million in the prior quarter.
  • The five-year high for Equity Average was $781.1 million in Q4 2021, with the low at -$213.4 million in Q4 2019.
  • Average Equity Average over 4 years is $352.3 million, with a median of $420.7 million recorded in 2022.
  • The sharpest move saw Equity Average skyrocketed 231.3% in 2020, then fell 28.16% in 2022.
  • Over 4 years, Equity Average stood at -$213.4 million in 2019, then surged by 231.3% to $280.2 million in 2020, then surged by 178.77% to $781.1 million in 2021, then dropped by 28.16% to $561.2 million in 2022.
  • According to Business Quant data, Equity Average over the past three periods came in at $561.2 million, $781.1 million, and $280.2 million for Q4 2022, Q4 2021, and Q4 2020 respectively.